Dremenia PWL-20
€0.00
Dive into a new era of hyperbaric oxygen therapy with the Dremenia PWL-20. This state-of-the-art hyperbaric chamber achieves a working pressure of up to 2 ATA, equivalent to a diving depth of 10 meters. The innovative tensioning strap technology enables a safe and mobile construction made of thermoplastic urethane (TPU), an extra-strong and durable material.
Maximum pressure with absolute safety
- Operating pressure: 2 bar absolute (corresponds to 10 meters diving depth)
- Diameter and lying surface: 760 mm diameter, 2,200 mm lying surface
- Weight: Only 18.5 kg – ideal for mobile use
- Material: High-strength thermoplastic urethane, reinforced with durable straps
- Valves: 2 automatic pressure control valves and 1 manual valve for precise control
Comfort and amenities
- Comfortable features: Latex mattress and pillow included, for maximum comfort
- Easy access: External or internal frame for convenient entry and exit as well as easy installation
Powerful supply unit
- Compressor: Air flow of 70 l/min, with a noise level of less than 55 dB
- Dimensions of the supply unit: 465 mm x 475 mm x 750 mm
- Weight of the supply unit: 69 kg
- Air cooler: Output of 150 l/min for pleasant temperatures inside
- Oxygen concentrator: Adjustable from 1 to 20 l/min, with up to 96% oxygen concentration
Flexibility and expandability
- Expandable options: Also available up to 2.8 ATA (only in conjunction with liquid oxygen from compressed gas cylinders)
- Mobile and powerful: Designed for flexible applications, both stationary and mobile
Your requirements, our expertise
Tell us your specific requirements and goals so we can provide you with comprehensive, personalized advice on hyperbaric oxygen therapy. With the Dremenia PWL-20, you're choosing a solution that combines maximum safety and the highest level of comfort.
Experience the future of hyperbaric oxygen therapy – with the Dremenia PWL-20. A product that makes no compromises and will exceed your expectations.
Dremenia – milde Überdruckkammern sind kein Medizinprodukt im Sinne der Verordnung (EU) 2017/745 des Europäischen Parlaments und des Rates vom 5. April 2017 über Medizinprodukte, zur Änderung der Richtlinie 2001/83/EG, der Verordnung (EG) Nr. 178/2002 und der Verordnung (EG) Nr. 1223/2009 und zur Aufhebung der Richtlinien 90/385/EWG und 93/42/EWG des Rates. Insbesondere werden sie nicht verwendet für: Diagnose, Prävention, Überwachung, Vorhersage, Prognose, Behandlung oder Linderung von Krankheiten, Verletzungen oder Behinderungen, einschließlich der Entschädigung für Verletzungen oder Behinderungen.








